Record NNP B-NP O
date NN I-NP O
: : O O
2150-02-09 CD O B-DATE
Educare-Fargo NNP B-NP B-HOSPITAL
B NNP I-NP O
Intern NNP I-NP O
Admission NNP I-NP O
Note NN I-NP O
Patient NNP B-NP O
: : O O
JACKS NNP B-NP I-PATIENT
, , O I-PATIENT
Yasseen NNP B-NP I-PATIENT
MR NNP B-NP O
# # I-NP O
: : O O
8841350 CD O B-MEDICALRECORD
Admit NNP B-NP O
Date NNP I-NP O
: : O O
2/09/50 CD O B-DATE
Location NN B-NP O
: : O O
West NNP B-NP O
208 CD I-NP O
Attending VBG B-VP O
: : O O
Dodge NNP O B-DOCTOR
PCP NNP B-NP O
: : O O
Dr. NNP B-NP O
Giovanni NNP I-NP B-DOCTOR
Gabriel NNP I-NP I-DOCTOR
( -LRB- I-NP O
KEKELA NNP I-NP B-HOSPITAL
/ NNP I-NP O
Keystone NNP I-NP B-CITY
Heights NNP I-NP I-CITY
) -RRB- O O
Source NN B-NP O
: : O O
Patient NNP B-NP O
, , I-NP O
chart NN I-NP O
, , O O
ED VBN B-NP O
pass-off NN I-NP O
Code NNP B-NP O
status NN I-NP O
: : O O
Full NNP B-NP O
( -LRB- I-NP O
presumed VBN B-VP O
) -RRB- O O
Contact NN B-NP O
: : O O
Son NN B-NP O
: : O O
Ursula NNP B-NP B-PATIENT
543-846-9534 CD I-NP B-PHONE
CC NNP B-NP O
: : O O
hypotension/unresponsiveness NN B-NP O
, , O O
cough NN B-NP O
HPI NNP B-NP O
: : O O
Mr. NNP B-NP O
Jacks NNP I-NP B-PATIENT
is VBZ B-VP O
an DT B-NP O
Indonesian NNP I-NP B-COUNTRY
83 CD I-NP B-AGE
M NNP I-NP O
w/ JJ I-NP O
HTN NNP I-NP O
, , O O
dementia NN B-NP O
, , O O
OA NNP B-NP O
and CC O O
severe JJ B-NP O
central JJ I-NP O
canal NN I-NP O
stenosis NN I-NP O
( -LRB- I-NP O
recent JJ I-NP O
RCH NN I-NP B-HOSPITAL
admission NN I-NP O
1/23 CD I-NP B-DATE
- : O O
2/03/50 CD B-NP B-DATE
for IN B-PP O
associated VBN B-NP O
LUE JJ I-NP O
weakness NN I-NP O
) -RRB- I-NP O
, , I-NP O
significant JJ I-NP O
smoking NN I-NP O
history NN I-NP O
, , O O
RUL NNP B-NP O
nodule NN I-NP O
( -LRB- I-NP O
since IN B-PP O
&#8217 CD B-NP O
; : O O
42 CD B-NP B-DATE
) -RRB- I-NP O
, , O O
and CC O O
h/o VBD B-VP O
bronchiectasis NN B-NP O
, , O O
who WP B-NP O
presents VBZ B-VP O
from IN B-PP O
his PRP$ B-NP O
nursing NN I-NP O
home NN I-NP O
w/ NN I-NP O
reported VBD B-VP O
episode NN B-NP O
of IN B-PP O
hypotension NN B-NP O
and CC I-NP O
unresponsiveness NN I-NP O
on IN B-PP O
2/08 CD B-NP B-DATE
around IN B-PP O
lunchtime NN B-NP O
. . O O
Per IN B-PP O
notes NNS B-NP O
, , O O
the DT B-NP O
pt NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
unresponsive JJ B-NP O
briefly NN I-NP O
after IN B-PP O
lunch NN B-NP O
, , O O
BP NNP B-NP O
was VBD B-VP O
checked VBN I-VP O
and CC O O
found VBN B-VP O
to TO I-VP O
be VB I-VP O
in IN B-PP O
the DT B-NP O
80&#8217 CD I-NP O
;s NNS I-NP O
systolic JJ B-ADJP O
, , O O
EMS NNP B-NP O
was VBD B-VP O
activated VBN I-VP O
and CC O O
an DT B-NP O
IV NNP I-NP O
was VBD B-VP O
placed VBN I-VP O
. . O O
He PRP B-NP O
quickly RB B-ADVP O
became VBD B-VP O
responsive JJ B-ADJP O
without IN B-PP O
intervention NN B-NP O
, , O O
and CC O O
BP NNP B-NP O
came VBD B-VP O
up RP B-PRT O
to TO B-PP O
the DT B-NP O
80s/90s CD I-NP O
. . O O
Per IN B-PP O
notes NNS B-NP O
, , O O
no DT B-NP O
reported VBD I-NP O
CP CD I-NP O
, , I-NP O
abdominal JJ I-NP O
pain NN I-NP O
, , O O
HA NNP B-NP O
, , O O
LH NNP B-NP O
, , O O
focal JJ B-NP O
neurological JJ I-NP O
symptoms NNS I-NP O
, , O O
SOB NNP B-NP O
, , O O
palpitations NNS B-NP O
. . O O
Of IN B-PP O
note NN B-NP O
, , O O
the DT B-NP O
pt NN I-NP O
was VBD B-VP O
recently RB I-VP O
hospitalized VBN I-VP O
at IN B-PP O
RCH NNP B-NP B-HOSPITAL
1/23 CD I-NP B-DATE
&#8211 CD I-NP O
; : O O
2/03/50 CD B-NP B-DATE
during IN B-PP O
which WDT B-NP O
time NN B-NP O
he PRP B-NP O
had VBD B-VP O
labile NN B-NP O
BP&#8217 CD I-NP O
;s NNS I-NP O
including VBG B-VP O
HTN NNP B-NP O
as RB I-NP O
well RB I-NP O
as IN I-NP O
question NN I-NP O
of IN B-PP O
orthostasis NN B-NP O
, , O O
and CC O O
was VBD B-VP O
discharged VBN I-VP O
on IN B-PP O
Hydralazine NNP B-NP O
, , O O
HCTZ NNP B-NP O
, , O O
Lisinopril NNP B-NP O
, , O O
and CC O O
Labetalol NNP B-NP O
, , O O
after IN B-PP O
having VBG B-VP O
taken VBN I-VP O
only RB B-NP O
Atenolol NNP I-NP O
and CC I-NP O
Terazosin NNP I-NP O
on IN B-PP O
admission NN B-NP O
. . O O
At IN B-PP O
rehab NN B-NP O
on IN B-PP O
2/05 CD B-NP B-DATE
( -LRB- I-NP O
3days VBZ B-VP O
PTA NNP B-NP O
) -RRB- I-NP O
, , O O
his PRP$ B-NP O
meds NNS I-NP O
were VBD B-VP O
changed VBN I-VP O
to TO B-PP O
Atenolol NNP B-NP O
, , O O
Terazosin NNP B-NP O
, , O O
HCTZ NNP B-NP O
, , O O
and CC O O
Lisinopril NNP B-NP O
. . O O
In IN B-PP O
the DT B-NP O
ED NNP I-NP O
, , O O
the DT B-NP O
pt&#8217 NN I-NP O
;s NN I-NP O
vitals NNS I-NP O
were VBD B-VP O
T NNP B-NP O
96.4 CD I-NP O
, , O O
HR NNP B-NP O
63 CD I-NP O
, , O O
BP NNP B-NP O
98/53 CD I-NP O
, , O O
RR NNP B-NP O
20 CD I-NP O
, , I-NP O
95 CD I-NP O
% NN I-NP O
on IN B-PP O
RA. NNP B-NP O
Labs NNP I-NP O
sig NN I-NP O
for IN B-PP O
Na NNP B-NP O
129 CD I-NP O
(up NN I-NP O
to TO B-PP O
131 CD B-NP O
after IN B-PP O
NS) NNP B-NP O
, , O O
Cr NNP B-NP O
1.58 CD I-NP O
( -LRB- I-NP O
baseline NN I-NP O
1.0 CD B-NP O
to TO I-NP O
1.1 CD B-NP O
but CC O O
recently RB B-NP O
1.4 CD I-NP O
to TO I-NP O
1.6) CD I-NP O
, , O O
WBC NNP B-NP O
9.2 CD I-NP O
up IN B-PP O
to TO B-PP O
15.6 CD B-NP O
(83 CD I-NP O
% NN I-NP O
PMN) NN I-NP O
during IN B-PP O
time NN B-NP O
in IN B-PP O
the DT B-NP O
ED NNP I-NP O
, , I-NP O
Hct NNP I-NP O
from IN B-PP O
38.3 CD B-NP O
to TO I-NP O
32.6 CD I-NP O
(MCV NN I-NP O
85 CD B-NP O
) -RRB- I-NP O
in IN I-NP O
ED VBN B-VP O
after IN B-PP O
fluids NNS B-NP O
( -LRB- O O
guaiac NN B-NP O
negative JJ I-NP O
) -RRB- I-NP O
, , O O
Head NNP B-NP O
CT NNP I-NP O
negative JJ I-NP O
, , O O
CXR NNP B-NP O
w/ VBD B-VP O
slightly RB B-ADJP O
more RBR I-ADJP O
prominent JJ I-ADJP O
bibasilar NN B-NP O
L NNP I-NP O
&gt NN I-NP O
; : O O
R NN B-NP O
opacities NNS I-NP O
. . O O
He PRP B-NP O
also RB B-ADVP O
c/o VBD B-VP O
cough NN B-NP O
while IN B-ADVP O
in IN B-PP O
the DT B-NP O
ED NNP I-NP O
, , O O
w/ IN B-PP O
no DT B-NP O
other JJ I-NP O
symptoms NNS I-NP O
, , O O
w/ VBP B-VP O
report NN B-NP O
of IN B-PP O
some DT B-NP O
rhonchorous JJ I-NP O
breath NN I-NP O
sounds NNS I-NP O
. . O O
Two CD B-NP O
sets NNS I-NP O
of IN B-PP O
blood NN B-NP O
cultures NNS I-NP O
were VBD B-VP O
drawn VBN I-VP O
, , O O
he PRP B-NP O
was VBD B-VP O
given VBN I-VP O
IVF NNP B-NP O
( -LRB- I-NP O
NS NNS I-NP O
) -RRB- B-VP O
at IN B-PP O
120cc/hr CD B-NP O
, , O O
and CC O O
he PRP B-NP O
started VBD B-VP O
on IN B-PP O
Vancomycin NNP B-NP O
and CC I-NP O
Cefepime NNP I-NP O
for IN B-PP O
presumed VBN B-NP O
PNA NNP I-NP O
. . O O
On IN B-PP O
the DT B-NP O
floor NN I-NP O
, , O O
the DT B-NP O
pt NN I-NP O
complains VBZ B-VP O
of IN B-PP O
cough NN B-NP O
, , O O
mildly RB B-ADVP O
productive JJ B-ADJP O
, , O O
but CC O O
no DT B-NP O
fevers/chills NNS I-NP O
, , O O
SOB NNP B-NP O
, , O O
DOE NNP B-NP O
, , O O
CP CD B-NP O
, , O O
hemoptysis NN B-NP O
, , O O
or CC O O
any DT B-NP O
other JJ I-NP O
sx NN I-NP O
, , O O
but CC O O
is VBZ B-VP O
somewhat RB B-ADVP O
of IN B-PP O
a DT B-NP O
poor JJ I-NP O
historian NN I-NP O
. . O O
Of IN B-PP O
note NN B-NP O
, , O O
pt NN B-NP O
had VBD B-VP O
recent JJ B-NP O
chest NN I-NP O
CT NNP I-NP O
( -LRB- I-NP O
I+ NN I-NP O
) -RRB- I-NP O
on IN B-PP O
1/27/50 CD B-NP B-DATE
to TO B-VP O
evaluate VB I-VP O
known VBN I-VP O
RUL NNP B-NP O
nodule NN I-NP O
, , O O
which WDT B-NP O
showed VBD B-VP O
likely JJ B-NP O
aspiration NN I-NP O
PNA NNP B-NP O
w/ VBD B-VP O
multifocal JJ B-NP O
dependent JJ I-NP O
consolidation NN I-NP O
. . B-VP O
Pt RB I-VP O
initially RB I-VP O
was VBD I-VP O
given VBN I-VP O
2days IN B-PP O
of IN B-PP O
Levofloxacin NNP B-NP O
, , O O
but CC O O
per IN B-PP O
Discharge NNP B-NP O
Summary NNP I-NP O
pt NN I-NP O
was VBD B-VP O
not RB I-VP O
clinically RB I-VP O
behaving VBG I-VP O
as IN B-ADJP O
if IN B-SBAR O
he PRP B-NP O
had VBD B-VP O
PNA NNP B-NP O
, , O O
so RB O O
Abx NNP B-NP O
were VBD B-VP O
stopped VBN I-VP O
. . O O
PMH NNP B-NP O
/ NNP I-NP O
PSH NNP I-NP O
: : O O
-HTN NN B-NP O
( -LRB- I-NP O
recent JJ I-NP O
med JJ I-NP O
adjustments NNS I-NP O
as IN B-PP O
above JJ B-NP O
) -RRB- O O
-Osteoarthritis NNP B-NP O
w/ VBD B-VP O
severe JJ B-NP O
central JJ I-NP O
canal NN I-NP O
stenosis NN I-NP O
, , O O
recent JJ B-NP O
admission NN I-NP O
1/50 IN B-PP B-DATE
w/ JJ B-NP O
LUE NNP I-NP O
weakness/ataxia NN I-NP O
, , O O
followed VBN B-VP O
by IN B-PP O
NSG/Neuro NNP B-NP O
, , O O
currently RB B-ADVP O
working VBG B-VP O
w/ IN B-PP O
PT NNP B-NP O
, , O O
in IN B-PP O
neck NN B-NP O
collar NN I-NP O
currently RB O O
-RUL JJ B-NP O
nodule NN I-NP O
first RB B-ADVP O
seen VBN B-VP O
2142 CD B-NP B-DATE
, , O O
recent JJ B-NP O
CT NNP I-NP O
I+ NNP I-NP O
on IN B-PP O
1/27/50 CD B-NP B-DATE
showed VBN I-NP O
-Left JJ B-NP O
Thyroid NNP I-NP O
nodule NN I-NP O
( -LRB- I-NP O
1.7cm IN B-PP O
) -RRB- B-NP O
noted VBD B-VP O
on IN B-PP O
CT NNP B-NP O
, , O O
unclear JJ B-ADJP O
h/o IN B-PP O
any DT B-NP O
workup NN I-NP O
-BPH . O O
-Bronchiectasis NN B-NP O
in IN B-PP O
lingula NN B-NP O
, , O O
h/o RB B-NP O
remote JJ I-NP O
?thoracotomy NN I-NP O
as IN B-PP O
child NN B-NP O
-Chronic JJ B-NP O
cough NN I-NP O
-Chronic JJ B-NP O
mild JJ I-NP O
thrombocytopenia NN I-NP O
Meds NNP B-NP O
at IN B-PP O
Home NNP B-NP O
: : O O
1 CD B-NP O
. . O O
Acetaminophen NNP O O
( -LRB- O O
Tylenol NNP B-NP O
) -RRB- I-NP O
325-650 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
Q4H NNP I-NP O
prn NN I-NP O
2. . B-NP O
Acetylsalicylic NNP I-NP O
Acid NNP I-NP O
( -LRB- I-NP O
Aspirin NN I-NP O
) -RRB- I-NP O
81 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
3. DT B-NP O
Atenolol NNP I-NP O
50 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
4 CD B-LST O
. . O O
Cyanocobalamin NNP B-NP O
( -LRB- I-NP O
Vitamin NN I-NP O
B12 NN I-NP O
) -RRB- I-NP O
1000 CD I-NP O
MCG NNP I-NP O
PO NNP I-NP O
QD . O O
5 CD B-NP O
. . O O
Docusate NNP B-NP O
Sodium NNP I-NP O
( -LRB- I-NP O
Colace NN I-NP O
) -RRB- I-NP O
100 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
BID NNP I-NP O
6 CD B-NP O
. . O O
Hydrochlorothiazide NNP B-NP O
25 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
7. DT B-NP O
Ipratropium NN I-NP O
Nebulizer NN I-NP O
( -LRB- I-NP O
Atrovent JJ I-NP O
Nebulizer NN I-NP O
) -RRB- I-NP O
0.5 CD I-NP O
MG NNP I-NP O
NEB NNP I-NP O
Q2H NNP I-NP O
prn NN I-NP O
8. CD B-NP O
Lisinopril NNP I-NP O
40 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
9 CD B-NP O
. . O O
Memantine NNP O O
( -LRB- O O
Namenda NN B-NP O
) -RRB- I-NP O
10 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
BID NNP I-NP O
10 CD B-NP O
. . O O
Methimazole NNP B-NP O
5 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
11 CD B-NP O
. . O O
Miconazole NNP B-NP O
Nitrate NNP I-NP O
2 CD I-NP O
% NN I-NP O
Powder NN I-NP O
1 CD I-NP O
APPLICATION NNP I-NP O
TOP NNP I-NP O
TID NNP I-NP O
prn NN I-NP O
12 CD B-NP O
. . O O
Multivitamins NNP B-NP O
1 CD I-NP O
TAB NNP I-NP O
PO NNP I-NP O
QD . O O
13 CD B-NP O
. . O O
Omeprazole NNP O O
( -LRB- O O
Prilosec NN B-NP O
) -RRB- I-NP O
20 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
BID NNP I-NP O
14 CD B-NP O
. . O O
Polyethylene NNP B-NP O
Glycol NNP I-NP O
( -LRB- I-NP O
Miralax NNP I-NP O
) -RRB- I-NP O
17 CD I-NP O
GM NNP I-NP O
PO NNP I-NP O
QD NNP I-NP O
prn NN I-NP O
15 CD B-NP O
. . O O
Simvastatin NNP B-NP O
80 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
16 CD B-NP O
. . O O
Terazosin NNP B-NP O
Hcl NNP I-NP O
10 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QHS . O O
17 CD B-NP O
. . O O
Trazodone NNP B-NP O
25 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QHS NNP I-NP O
prn NN I-NP O
anxiety NN I-NP O
,insomnia NN I-NP O
,agitation NN I-NP O
All DT B-NP O
: : O O
NKDA NNP O O
SH NNS B-NP O
: : O O
Currently RB B-ADVP O
living VBG B-VP O
at IN B-PP O
Lew NNP B-NP B-HOSPITAL
Healthcare NNP I-NP I-HOSPITAL
Clinic NNP I-NP I-HOSPITAL
; : O O
normally RB B-ADVP O
lives VBZ B-VP O
w/ VBN B-NP O
wife NN I-NP O
in IN B-PP O
apartment NN B-NP O
. . O O
Retired VBN B-VP O
Plasterer NNP B-NP B-PROFESSION
. . I-NP O
Significant NNP I-NP O
smoking VBG I-NP O
history NN I-NP O
but CC O O
none NN B-NP O
currently RB B-ADVP O
. . O O
No DT B-NP O
EtOH NNP I-NP O
or CC I-NP O
illicits NNS I-NP O
. . O O
FH NNP B-NP O
: : O O
NC NNP O O
ROS NNP B-NP O
: : O O
As IN B-PP O
in IN B-PP O
HPI NNP B-NP O
; : O O
poor JJ B-NP O
historian NN I-NP O
. . O O
Additionally RB O O
: : O O
Denies NNS B-NP O
fevers/chills NNS I-NP O
, , O O
diaphoresis NN B-NP O
Denies NNS B-NP O
HA NNP I-NP O
, , O O
vision NN B-NP O
changes NNS I-NP O
, , O O
weakness NN B-NP O
Denies NNS B-NP O
CP CD B-NP O
, , O O
chest NN B-NP O
pressure NN I-NP O
, , O O
palpitations NNS B-NP O
, , O O
orthopnea NN B-NP O
, , O O
PND NNP B-NP O
, , O O
LH . O O
Denies NNS B-NP O
SOB NNP I-NP O
, , O O
wheeze NN B-NP O
, , O O
DOE VB O O
Denies NNS B-NP O
n/v/d NN I-NP O
, , O O
constipation NN B-NP O
, , O O
melena NN B-NP O
, , O O
hematochezia NN B-NP O
Denies NNS B-NP O
dysuria NN I-NP O
, , O O
frequency NN B-NP O
, , O O
hematuria NN B-NP O
Denies NNS B-NP O
recent JJ I-NP O
travel NN I-NP O
Exam NNP B-NP O
: : O O
T NNP B-NP O
98.6 CD I-NP O
HR NNP B-NP O
70 CD I-NP O
BP NNP B-NP O
140/67 CD I-NP O
RR NN B-NP O
18 CD I-NP O
O2 IN B-PP O
95 CD B-NP O
% NN I-NP O
RA NNP I-NP O
Gen NNP B-NP O
: : O O
NAD NNP B-NP O
, , I-NP O
alert JJ I-NP O
, , I-NP O
conversant JJ I-NP O
, , I-NP O
pleasant JJ I-NP O
, , O O
wearing VBG B-VP O
neck NN B-NP O
collar NN I-NP O
HEENT NNP B-NP O
: : O O
NC/AT NN B-NP O
, , O O
PERRL NNP B-NP O
, , O O
nonicteric JJ B-ADJP O
. . B-NP O
EOMI NNP I-NP O
. . I-NP O
MM NNP I-NP O
dry JJ I-NP O
, , I-NP O
w/o JJ I-NP O
exudates NNS I-NP O
. . O O
Neck NNP B-NP O
: : O O
Supple NNP B-NP O
, , O O
NT NNP B-NP O
, , O O
full JJ B-NP O
ROM NNP I-NP O
, , O O
2+ CD B-NP O
carotids NNS I-NP O
w/o IN B-PP O
bruits NNS B-NP O
, , O O
no DT B-NP O
LAD. NNP I-NP O
JVP NNP I-NP O
7cm NNP I-NP O
. . O O
Pulm NNP B-NP O
: : O O
Decreased JJ B-NP O
BS NNP I-NP O
bilaterally RB B-ADVP O
, , O O
faint JJ B-NP O
bibasilar NN I-NP O
crackles NNS I-NP O
, , O O
no DT B-NP O
wheezes NNS I-NP O
Cor NNP B-NP O
: : O O
RRR NNP B-NP O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
S2 NNP I-NP O
, , O O
no DT B-NP O
m/r/g NN I-NP O
appreciated VBN O O
Abd NNP B-NP O
: : O O
Soft NNP B-NP O
, , O O
non-distended JJ B-NP O
, , I-NP O
non-tender JJ I-NP O
, , I-NP O
BS+ NNP I-NP O
, , O O
no DT B-NP O
HSM NNP I-NP O
, , I-NP O
guaiac JJ I-NP O
neg NN I-NP O
in IN B-PP O
ED VBN O O
Extr NNP B-NP O
: : O O
No DT B-NP O
LE JJ I-NP O
edema NN I-NP O
, , O O
2+ IN B-PP O
DP NNP B-NP O
's POS B-NP O
bilaterally NN I-NP O
Neuro NNP B-NP O
: : O O
AOx~2 NN B-NP O
( -LRB- I-NP O
&#8220 CD I-NP O
; : O O
March NNP B-NP B-DATE
2150 CD I-NP I-DATE
&#8221; NN I-NP O
, , O O
knew VBD B-VP O
we PRP B-NP O
were VBD B-VP O
in IN B-PP O
&#8220 CD B-NP O
;hospital&#8221 CD I-NP O
; : O O
) -RRB- B-NP O
, , O O
CN NNP B-NP O
II NNP I-NP O
through IN B-PP O
XII NNP B-NP O
intact JJ I-NP O
, , I-NP O
motor NN I-NP O
and CC I-NP O
sensory JJ I-NP O
nonfocal JJ I-NP O
( -LRB- I-NP O
LUE JJ I-NP O
strength NN I-NP O
WNL NNP I-NP O
) -RRB- I-NP O
, , O O
DTR NNP B-NP O
's POS B-NP O
2+ JJ I-NP O
and CC I-NP O
symmetric JJ I-NP O
, , O O
no DT B-NP O
meningismus NN I-NP O
or CC I-NP O
photophobia NN I-NP O
Labs/Rads NNS B-NP O
: : O O
08-Feb-2150 CD B-NP B-DATE
15:38 CD I-NP O
Plasma NNP B-NP O
Sodium NNP I-NP O
129 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
135-145 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Plasma NNP B-NP O
Potassium NNP I-NP O
3.7 CD I-NP O
( -LRB- I-NP O
3.4-4.8 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Plasma NNP B-NP O
Chloride NNP I-NP O
86 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
100-108 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Plasma NNP B-NP O
Carbon NNP I-NP O
Dioxide NNP I-NP O
35.9 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
23.0-31.9 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Calcium NN B-NP O
8.8 CD I-NP O
( -LRB- I-NP O
8.5-10.5 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Phosphorus NNP B-NP O
3.7 CD I-NP O
( -LRB- I-NP O
2.6-4.5 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Magnesium NNP B-NP O
2.1 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
1.4-2.0) CD I-NP O
meq/L NN I-NP O
Plasma NNP B-NP O
Urea NNP I-NP O
Nitrogen NNP I-NP O
51 CD I-NP O
H NNP B-NP O
(8-25 . O O
) -RRB- O O
mg/dl . O O
Plasma NNP B-NP O
Creatinine NNP I-NP O
1.58 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
0.60-1.50 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
eGFR NN B-NP O
45 CD I-NP O
mL/min/1.73m2 . O O
Plasma NNP B-NP O
Glucose NNP I-NP O
125 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
70-110 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Cardiac NNP B-NP O
enzymes VBZ B-VP O
negative JJ B-NP O
x NN I-NP O
1 CD O O
WBC NNP B-NP O
9.2 CD I-NP O
( -LRB- I-NP O
4.5-11.0) JJ I-NP O
th/cmm NN I-NP O
HCT NNP B-NP O
38.3 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
41.0-53.0) CD I-NP O
% NN I-NP O
HGB NN B-NP O
13.7 CD I-NP O
( -LRB- I-NP O
13.5-17.5 CD I-NP O
) -RRB- I-NP O
gm/dl . O O
RBC NNP B-NP O
4.42 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
4.50-5.90 CD I-NP O
) -RRB- I-NP O
mil/cmm . O O
PLT NNP B-NP O
184 CD I-NP O
( -LRB- I-NP O
150-400 CD I-NP O
) -RRB- I-NP O
th/cumm . O O
MCV NN B-NP O
87 CD I-NP O
( -LRB- I-NP O
80-100 CD B-PP O
) -RRB- B-NP O
fl NN I-NP O
MCH NNP B-NP O
30.9 CD I-NP O
( -LRB- I-NP O
26.0-34.0) JJ I-NP O
pg/rbc NN I-NP O
MCHC NNP B-NP O
35.7 CD I-NP O
( -LRB- O O
31.0-37.0) CD B-NP O
g/dl NN I-NP O
RDW NNP B-NP O
12.5 CD I-NP O
( -LRB- I-NP O
11.5-14.5 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
DIFFERENTIAL NNP B-NP O
REQUEST NNP I-NP O
RECEIVED NNP I-NP O
Diff JJ B-NP O
Method NNP I-NP O
Auto NN I-NP O
Poly NNP B-NP O
78 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
40-70 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
Lymphs NNP B-NP O
19 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
22-44 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
Monos NNP B-NP O
2 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
4-11 NN I-NP O
) -RRB- B-NP O
% NN I-NP O
EOS NNS B-NP O
1 CD B-NP O
(0-8 CD I-NP O
) -RRB- O O
% NN O O
Basos NNS B-NP O
0 CD B-NP O
(0-3 JJ I-NP O
) -RRB- I-NP O
% NN I-NP O
Absolute JJ B-NP O
Neuts NNP I-NP O
7.20 CD I-NP O
( -LRB- I-NP O
1.8-7.7 CD I-NP O
) -RRB- I-NP O
th/cmm . O O
Absolute JJ B-NP O
Lymphs NNP I-NP O
1.73 CD I-NP O
( -LRB- I-NP O
1.0-4.8 CD I-NP O
) -RRB- I-NP O
th/cmm . O O
Absolute JJ B-NP O
Monos NNP I-NP O
0.19 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
0.2-0.4 CD I-NP O
) -RRB- I-NP O
th/cmm . O O
Absolute JJ B-NP O
EOS NNP I-NP O
0.07 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
0.1-0.3 CD I-NP O
) -RRB- I-NP O
th/cmm . O O
Absolute JJ B-NP O
Basos NNP I-NP O
0.02 CD I-NP O
( -LRB- I-NP O
0.0-0.3 CD I-NP O
) -RRB- I-NP O
th/cmm . O O
Aniso NNP B-NP O
None NN I-NP O
( -LRB- I-NP O
None NN I-NP O
) -RRB- O O
Hypo NNP B-NP O
None NN I-NP O
( -LRB- I-NP O
None NN I-NP O
) -RRB- O O
Macrocytes NNP B-NP O
None NN I-NP O
( -LRB- I-NP O
None NN I-NP O
) -RRB- O O
Microcytes NNS B-NP O
None NN B-VP O
( -LRB- B-NP O
None NN I-NP O
) -RRB- O O
Blood NN B-NP O
cultures NNS I-NP O
negative JJ B-NP O
x NN I-NP O
2 CD O O
CXR NNP B-NP O
2/08 CD I-NP B-DATE
: : O O
IMPRESSION NN B-NP O
: : O O
Slightly RB B-NP O
more RBR I-NP O
prominent JJ I-NP O
opacities NNS I-NP O
at IN B-PP O
the DT B-NP O
left JJ I-NP O
base NN I-NP O
CT NNP B-NP O
Brain NNP I-NP O
2/08 CD I-NP B-DATE
: : O O
IMPRESSION NN B-NP O
: : O O
No DT B-NP O
acute JJ I-NP O
infarct NN I-NP O
, , O O
acute JJ B-NP O
parenchymal NN I-NP O
abnormality NN I-NP O
, , O O
extra-axial JJ B-NP O
fluid NN I-NP O
collection NN B-NP O
, , O O
midline JJ B-NP O
shift NN I-NP O
, , O O
mass JJ B-NP O
effect NN I-NP O
, , O O
or CC O O
hemorrhage NN B-NP O
is VBZ B-VP O
seen VBN I-VP O
. . O O
Nonspecific JJ B-NP O
white JJ I-NP O
matter NN I-NP O
foci NNS I-NP O
, , O O
likely JJ B-NP O
representing VBG B-VP O
chronic JJ B-NP O
small JJ I-NP O
vessel NN B-NP O
ischemic JJ I-NP O
changes NNS I-NP O
, , O O
and CC O O
mild JJ B-NP O
generalized JJ I-NP O
volume NN I-NP O
loss NN I-NP O
. . O O
Unchanged JJ B-NP O
anterior JJ I-NP O
nasal JJ I-NP O
septal JJ I-NP O
defect NN I-NP O
, , O O
anterior JJ B-NP O
subluxation NN I-NP O
of IN B-PP O
the DT B-NP O
left JJ I-NP O
TMJ, NNP I-NP O
and CC O O
marked VBD B-VP O
degenerative JJ B-NP O
changes NNS I-NP O
of IN B-PP O
the DT B-NP O
C1/C2 NN I-NP O
articulation NN B-NP O
. . O O
Chest NNP B-NP O
CT NNP I-NP O
I+ NNP I-NP O
1/27/50 CD I-NP B-DATE
: : O O
IMPRESSION NN B-NP O
: : O O
Multifocal JJ B-NP O
dependent JJ I-NP O
consolidation NN I-NP O
, , O O
suggesting VBG B-VP O
aspiration NN B-NP O
pneumonia NN B-NP O
. . O O
New NNP B-NP O
small JJ I-NP O
left JJ I-NP O
pleural JJ I-NP O
effusion NN I-NP O
. . O O
Enlarged VBN B-NP O
prevascular JJ I-NP O
lymph NN I-NP O
node NN I-NP O
and CC I-NP O
increase NN I-NP O
in IN B-PP O
size NN B-NP O
of IN B-PP O
prevascular JJ B-NP O
lymph NN I-NP O
nodes NNS I-NP O
. . O O
Central NNP B-NP O
left VBD B-VP O
peribronchial JJ B-NP O
thickening NN I-NP O
, , O O
most RBS B-NP O
likely JJ I-NP O
represent VB B-LST O
secretions NNS B-NP O
and/or CC O O
reactive VB B-VP O
lymphoid JJ B-NP O
tissues NNS I-NP O
. . O O
Follow-up NN B-NP O
chest NN I-NP O
CT . O O
in IN B-PP O
six CD B-NP O
weeks NNS I-NP O
for IN B-PP O
resolution NN B-NP O
. . O O
New NNP B-NP O
trace NN I-NP O
pericardial JJ I-NP O
effusion NN I-NP O
. . O O
Thyroid NNP B-NP O
nodule NN I-NP O
. . O O
EKG NNP B-NP O
: : O O
NSR NNP B-NP O
at IN B-PP O
75bpm NNP B-NP O
, , O O
Q&#8217 CD B-NP O
;s NNS I-NP O
in IN B-PP O
III NNP B-NP O
and CC I-NP O
AVF NNP I-NP O
, , O O
left VBD B-VP O
axis PRP$ I-VP O
Impression/Plan NN B-NP O
: : O O
83 CD B-NP B-AGE
M NNP I-NP O
w/ JJ I-NP O
HTN NNP I-NP O
, , O O
dementia NN B-NP O
, , O O
OA NNP B-NP O
and CC O O
central JJ B-NP O
canal NN I-NP O
stenosis NN I-NP O
, , O O
smoking VBG B-VP O
history NN B-NP O
, , O O
stable JJ B-NP O
RUL NNP I-NP O
nodule NN I-NP O
, , O O
h/o IN B-PP O
bronchiectasis NN B-NP O
, , O O
recent JJ B-NP O
imaging NN I-NP O
suggestive NN I-NP O
of IN B-PP O
aspiration NN B-NP O
PNA NNP I-NP O
, , O O
and CC O O
recent JJ B-NP O
BP NNP I-NP O
med JJ I-NP O
changes NNS I-NP O
, , O O
who WP B-NP O
presents VBZ B-VP O
w/ PRP B-NP O
hypotension NN B-NP O
and CC O O
brief JJ B-NP O
unresponsiveness NN I-NP O
at IN B-PP O
rehab NN B-NP O
per IN B-PP O
note NN B-NP O
. . O O
Here RB B-ADVP O
w/ , O O
WBC NNP B-NP O
elevation NN I-NP O
, , O O
cough NN B-NP O
mildly RB B-ADJP O
productive JJ I-ADJP O
, , O O
no DT B-NP O
fevers/chills/myalgias NN I-NP O
or CC I-NP O
concern NN I-NP O
for IN B-PP O
influenza NN B-NP O
, , O O
but CC O O
concern NN B-NP O
for IN B-PP O
PNA NNP B-NP O
, , O O
especially RB B-ADVP O
aspiration IN B-PP O
PNA NNP B-NP O
given VBN B-VP O
prior RB B-NP O
CT JJ I-NP O
findings NNS I-NP O
, , O O
CXR NNP B-NP O
w/ VBD B-VP O
increased VBN I-VP O
L NNP B-NP O
opacity NN I-NP O
. . O O
Will MD B-VP O
need VB I-VP O
to TO I-VP O
exonerate VB I-VP O
urine NN B-NP O
and CC I-NP O
blood NN I-NP O
as RB B-ADVP O
well RB I-ADVP O
; : O O
no DT B-NP O
meningismus NN I-NP O
on IN B-PP O
exam NN B-NP O
. . O O
In IN B-PP O
terms NNS B-NP O
of IN B-PP O
the DT B-NP O
hypotensive JJ I-NP O
episode NN I-NP O
, , O O
likely JJ B-ADJP O
in IN B-PP O
setting VBG B-VP O
of IN B-PP O
mild JJ B-NP O
hypovolemia NN I-NP O
plus IN B-PP O
several JJ B-NP O
new JJ I-NP O
BP NNP I-NP O
meds NNS I-NP O
from IN B-PP O
recent JJ B-NP O
discharge NN I-NP O
, , O O
plus CC O O
further JJ B-NP O
titration NN I-NP O
at IN B-PP O
rehab NN B-NP O
in IN B-PP O
preceding VBG B-VP O
few JJ B-NP O
days NNS I-NP O
. . O O
Mildly NNP B-NP O
dry JJ I-NP O
on IN B-PP O
exam NN B-NP O
, , O O
w/ WRB B-ADVP O
likely JJ B-NP O
hypovolemic JJ I-NP O
hypoNa NN I-NP O
but CC O O
will MD B-VP O
follow VB I-VP O
. . B-NP O
Hct NNP I-NP O
drop NN I-NP O
since IN B-PP O
arrival NN B-NP O
, , O O
will MD B-VP O
re-check VB I-VP O
, , O O
possibly RB B-ADVP O
dilutional JJ B-NP O
, , I-NP O
guaiac JJ I-NP O
negative JJ I-NP O
. . O O
** NN B-NP O
Infection NNP I-NP O
/ NNP I-NP O
PNA . O O
--obtain JJ B-NP O
sputum NN I-NP O
sample NN I-NP O
--Vanco NNP B-NP O
and CC I-NP O
Cefepime NNP I-NP O
given VBN I-NP O
cough NN I-NP O
and CC O O
WBC NNP B-NP O
elev NN I-NP O
, , O O
presumed VBN B-VP O
HAP NNP B-NP O
( -LRB- I-NP O
possibly RB I-NP O
aspiration NN I-NP O
) -RRB- O O
--obtain JJ B-NP O
U/A NNP I-NP O
since IN B-SBAR O
none NN B-NP O
obtained VBD B-VP O
in IN B-PP O
ED VBN O O
--f/u JJ B-NP O
blood NN I-NP O
ctx NN I-NP O
x NN I-NP O
2 CD O O
** JJ B-NP O
Hypotension NNP I-NP O
on IN B-PP O
arrival NN B-NP O
--infectious JJ B-NP O
workup NN I-NP O
/ NN I-NP O
treatment NN I-NP O
as IN B-PP O
above IN O O
--will NN B-NP O
only RB B-ADVP O
give VB B-VP O
Labetalol NNP B-NP O
and CC I-NP O
Hydralazine NNP I-NP O
for IN B-PP O
now RB B-NP O
( -LRB- I-NP O
holding VBG I-NP O
ACEi NNP I-NP O
, , O O
HCTZ NNP B-NP O
given VBN B-VP O
mild JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
above IN B-PP O
prior JJ B-NP O
baseline NN I-NP O
) -RRB- I-NP O
, , O O
add VB B-VP O
back RB B-ADVP O
Terazosin RB I-ADVP O
as IN B-SBAR O
necessary JJ B-UCP O
--gentle JJ B-NP O
IVF NNP I-NP O
overnight RB B-ADVP O
, , O O
re-check NN B-NP O
a.m. NN I-NP O
lytes NNS I-NP O
( -LRB- O O
likely RB B-NP O
mild JJ I-NP O
hypovolemic JJ I-NP O
hyponatremia NN I-NP O
) -RRB- I-NP O
and CC I-NP O
orthostatics NNS I-NP O
after IN B-PP O
volume NN B-NP O
challenge NN I-NP O
** NN B-NP O
Anemia NNP I-NP O
--guaiac JJ B-NP O
negative JJ I-NP O
in IN B-PP O
ED NNP B-NP O
, , O O
will MD B-VP O
guaiac VB I-VP O
all DT B-NP O
stools NNS I-NP O
, , I-NP O
type NN I-NP O
and CC I-NP O
cross NN I-NP O
--f/u NN B-NP O
rpt NN I-NP O
Hct NN I-NP O
, , O O
consider VB B-VP O
iron NN B-NP O
studies NNS I-NP O
, , O O
retic JJ B-NP O
, , I-NP O
etc FW I-NP O
. . O O
** NN B-NP O
Renal NNP I-NP O
failure NN I-NP O
--at JJ B-NP O
same JJ I-NP O
Cr NNP I-NP O
as IN B-PP O
last JJ B-NP O
week NN I-NP O
&#8217 IN B-PP O
;s NNP B-NP O
admission NN I-NP O
, , O O
but CC O O
up RB B-ADVP O
from IN B-PP O
his PRP$ B-NP O
baseline NN I-NP O
; : O O
BUN/Cr NNP B-NP O
ratio NN I-NP O
appears VBZ B-VP O
c/w JJ B-NP O
pre-renal JJ I-NP O
picture NN I-NP O
, , O O
will MD B-VP O
check VB I-VP O
urine NN B-NP O
lytes NNS I-NP O
, , O O
assess VBP B-VP O
response NN B-NP O
to TO B-PP O
IVF NNP B-NP O
** NN B-NP O
FEN NNS I-NP O
--Regular JJ B-NP O
no DT I-NP O
salt NN I-NP O
added VBD B-VP O
diet NN B-NP O
w/ NNS I-NP O
Aspiration IN B-PP O
precautions NNS B-NP O
; : O O
gentle JJ B-NP O
IVF NN I-NP O
as IN B-PP O
above IN O O
--S+S NNS B-NP O
consult VB O O
** NN B-NP O
Ppx NNP I-NP O
/ NNP I-NP O
Other JJ O O
--heparin NNP B-NP O
sc NN I-NP O
, , O O
PPI NNP B-NP O
, , O O
bowel NN B-NP O
regimen NNS I-NP O
--Full JJ B-NP O
code NN I-NP O
for IN B-PP O
now RB B-NP O
, , O O
re-assess NN B-NP O
w/ NN I-NP O
son NN I-NP O
tomorrow NN I-NP O
Howard NNP B-NP B-DOCTOR
G. NNP I-NP I-DOCTOR
Xiong NNP I-NP I-DOCTOR
, , O O
MD . O O
PGY-1 NN B-NP O
Pager NNP B-NP O
# # I-NP O
17730 CD O B-PHONE
